BioCentury
ARTICLE | Company News

Plantacor, University of Texas M.D. Anderson Cancer Center deal

August 2, 2004 7:00 AM UTC

Plantacor received exclusive licenses to three preclinical cancer therapeutics from the university. They include liposomal formulations of plant extracts curcumin and emodin to treat cancers such as l...